Miglietta, Federica
Griguolo, Gaia
Bottosso, Michele http://orcid.org/0000-0002-8098-1819
Giarratano, Tommaso
Lo Mele, Marcello
Fassan, Matteo http://orcid.org/0000-0001-6515-5482
Cacciatore, Matilde
Genovesi, Elisa
De Bartolo, Debora
Vernaci, Grazia http://orcid.org/0000-0003-4401-7579
Amato, Ottavia http://orcid.org/0000-0002-3690-8542
Conte, PierFranco
Guarneri, Valentina http://orcid.org/0000-0002-2375-8397
Dieci, Maria Vittoria http://orcid.org/0000-0002-3967-9861
Funding for this research was provided by:
Università degli Studi di Padova (BIRD 2019, BIRD 2020, DOR-1830512/18, DOR-2194859/21)
Article History
Received: 23 April 2021
Accepted: 28 July 2021
First Online: 12 October 2021
Change Date: 24 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41523-021-00359-w
Competing interests
: M.F. received honoraria for consulting, advisory role, speaker bureau, and/or research funding from Astellas Pharma, QED Therapeutics, Diaceutics, Tesaro, Roche, Eli Lilly, and Novartis, all outside the submitted work. PFC reports personal fees from Novartis, EliLilly, AstraZeneca, Tesaro, BMS, Roche, all outside the submitted work. V.G.: reports personal fees from Roche, Novartis, Eli Lilly, MSD outside the submitted work. MVD reports personal fees from Lilly, Genomic Health, Novartis and Celgene, all outside the submitted work. All remaining authors have declared no conflicts of interest.